{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:35:43Z","timestamp":1761514543178,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10147-020-01640-x","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T13:02:52Z","timestamp":1583499772000},"page":"1178-1186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of a routine second curettage for hydatidiform mole: a cohort study"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0517-5091","authenticated-orcid":false,"given":"Eiko","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiro","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"issue":"6","key":"1640_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","volume":"203","author":"JR Lurain","year":"2010","unstructured":"Lurain JR (2010) Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 203(6):531\u2013539. https:\/\/doi.org\/10.1016\/j.ajog.2010.06.073","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1640_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3892\/ijmm.2017.3067","volume":"40","author":"E Yamamoto","year":"2017","unstructured":"Yamamoto E, Niimi K, Kiyono T et al (2017) Establishment and characterization of cell lines derived from complete hydatidiform mole. Int J Mol Med 40(3):614\u2013622. https:\/\/doi.org\/10.3892\/ijmm.2017.3067","journal-title":"Int J Mol Med"},{"issue":"9742","key":"1640_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","volume":"376","author":"MJ Seckl","year":"2010","unstructured":"Seckl MJ, Sebire NJ, Berkowitz RS (2010) Gestational trophoblastic disease. Lancet 376(9742):717\u2013729. https:\/\/doi.org\/10.1016\/S0140-6736(10)60280-2","journal-title":"Lancet"},{"issue":"7","key":"1640_CR4","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1111\/j.1349-7006.2010.01602.x","volume":"101","author":"E Kaneki","year":"2010","unstructured":"Kaneki E, Kobayashi H, Hirakawa T et al (2010) Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease. Cancer Sci 101(7):1717\u20131721. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01602.x","journal-title":"Cancer Sci"},{"issue":"7\u20138","key":"1640_CR5","first-page":"373","volume":"61","author":"M Kan","year":"2016","unstructured":"Kan M, Yamamoto E, Niimi K et al (2016) Gestational trophoblastic neoplasia and pregnancy outcome after routine second curettage for hydatidiform mole a retrospective observational study. J Reprod Med 61(7\u20138):373\u2013379","journal-title":"J Reprod Med"},{"issue":"2","key":"1640_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ygyno.2011.10.035","volume":"124","author":"WD Kang","year":"2012","unstructured":"Kang WD, Choi HS, Kim SM (2012) Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole. Gynecol Oncol 124(2):250\u2013253. https:\/\/doi.org\/10.1016\/j.ygyno.2011.10.035","journal-title":"Gynecol Oncol"},{"issue":"1\u20132","key":"1640_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejogrb.2006.01.024","volume":"128","author":"LC Horn","year":"2006","unstructured":"Horn LC, Kowalzik J, Bilek K et al (2006) Clinicopathologic characteristics and subsequent pregnancy outcome in 139 complete hydatidiform moles. Eur J Obstet Gynecol Reprod Biol 128(1\u20132):10\u201314. https:\/\/doi.org\/10.1016\/j.ejogrb.2006.01.024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"11","key":"1640_CR8","first-page":"902","volume":"51","author":"CM Feltmate","year":"2006","unstructured":"Feltmate CM, Growdon WB, Wolfberg AJ et al (2006) Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med 51(11):902\u2013906","journal-title":"J Reprod Med"},{"issue":"5","key":"1640_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.tjog.2019.07.012","volume":"58","author":"A Sato","year":"2019","unstructured":"Sato A, Usui H, Shozu M (2019) Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidiform moles. Taiwan J Obstet Gynecol 58(5):650\u2013655. https:\/\/doi.org\/10.1016\/j.tjog.2019.07.012","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"16","key":"1640_CR10","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMcp0900696","volume":"360","author":"RS Berkowitz","year":"2009","unstructured":"Berkowitz RS, Goldstein DP (2009) Clinical practice. Molar pregnancy. N Engl J Med 360(16):1639\u20131645. https:\/\/doi.org\/10.1056\/NEJMcp0900696","journal-title":"N Engl J Med"},{"issue":"3","key":"1640_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ygyno.2011.05.035","volume":"122","author":"M Alazzam","year":"2011","unstructured":"Alazzam M, Young T, Coleman R et al (2011) Predicting gestational trophoblastic neoplasia (GTN): is urine hCG the answer? Gynecol Oncol 122(3):595\u2013599. https:\/\/doi.org\/10.1016\/j.ygyno.2011.05.035","journal-title":"Gynecol Oncol"},{"key":"1640_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-019-01540-9","author":"S Sato","year":"2019","unstructured":"Sato S, Yamamoto E, Niimi K et al (2019) The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia. Int J Clin Oncol. https:\/\/doi.org\/10.1007\/s10147-019-01540-9","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"1640_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ygyno.2004.02.018","volume":"93","author":"S Goto","year":"2004","unstructured":"Goto S, Ino K, Mitsui T et al (2004) Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births. Gynecol Oncol 93(2):529\u2013535. https:\/\/doi.org\/10.1016\/j.ygyno.2004.02.018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1640_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/00016348709103641","volume":"66","author":"TT Lao","year":"1987","unstructured":"Lao TT, Lee FH, Yeung SS (1987) Repeat curettage after evacuation of hydatidiform mole An appraisal. Acta Obstet Gynecol Scand 66(4):305\u2013307","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1640_CR15","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1053\/plac.2002.0933","volume":"24","author":"S Sasaki","year":"2003","unstructured":"Sasaki S (2003) Management of gestational trophoblastic diseases in Japan a review. Placenta 24:S28\u201332","journal-title":"Placenta"},{"key":"1640_CR16","unstructured":"Yamamoto E, Trinh TD, Sekiya Y, Tamakoshi K, Nguyen XP, Nishino K, Niimi K, Kotani T, Kajiyama H, Shibata K, Le QT, Kikkawa F (2020) The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study. Nagoya J Med Sci 82 (in press)"},{"issue":"2","key":"1640_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ajog.2006.10.867","volume":"196","author":"F Golfier","year":"2007","unstructured":"Golfier F, Raudrant D, Frappart L et al (2007) First epidemiological data from the French Trophoblastic Disease Reference Center. Am J Obstet Gynecol 196(2):171\u2013175. https:\/\/doi.org\/10.1016\/j.ajog.2006.10.867","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1640_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ygyno.2005.06.032","volume":"99","author":"NE van Trommel","year":"2005","unstructured":"van Trommel NE, Massuger LF, Verheijen RH et al (2005) The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey. Gynecol Oncol 99(1):6\u201313. https:\/\/doi.org\/10.1016\/j.ygyno.2005.06.032","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1640_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/AOG.0000000000001554","volume":"128","author":"RJ Osborne","year":"2016","unstructured":"Osborne RJ, Filiaci VL, Schink JC et al (2016) Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia. Obstet Gynecol 128(3):535\u2013542. https:\/\/doi.org\/10.1097\/AOG.0000000000001554","journal-title":"Obstet Gynecol"},{"key":"1640_CR20","unstructured":"The Japan Society of Obstetrics and Gynecology, The Japanese Pathological Society (1995) The general rules for clinical and pathological management of trophoblastic disease (written in Japanese). Second Edition. Igaku-shoin, Tokyo"},{"key":"1640_CR21","unstructured":"The Japan Society of Obstetrics and Gynecology, The Japanese Pathological Society (2011) The general rules for clinical and pathological management of trophoblastic disease (written in Japanese). Third Edition. Igaku-shoin, Tokyo"},{"issue":"4","key":"1640_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000106496","volume":"64","author":"S Sumigama","year":"2007","unstructured":"Sumigama S, Itakura A, Yamamoto T et al (2007) Genetically identified complete hydatidiform mole coexisting with a live twin fetus: comparison with conventional diagnosis. Gynecol Obstet Invest 64(4):228\u2013231. https:\/\/doi.org\/10.1159\/000106496","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"1640_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1525-1438.2001.011001073.x","volume":"11","author":"EI Kohorn","year":"2001","unstructured":"Kohorn EI (2001) The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer 11(1):73\u201377","journal-title":"Int J Gynecol Cancer"},{"key":"1640_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.gore.2017.07.011","volume":"21","author":"K Niimi","year":"2017","unstructured":"Niimi K, Yamamoto E, Nishino K et al (2017) Spontaneous regression of gestational trophoblastic neoplasia. Gynecol Oncol Rep 21:98\u2013100. https:\/\/doi.org\/10.1016\/j.gore.2017.07.011","journal-title":"Gynecol Oncol Rep"},{"issue":"9223","key":"1640_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(00)02432-6","volume":"356","author":"MJ Seckl","year":"2000","unstructured":"Seckl MJ, Fisher RA, Salerno G et al (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356(9223):36\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(00)02432-6","journal-title":"Lancet"},{"issue":"3 Pt 1","key":"1640_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/gyno.2000.5839","volume":"78","author":"JA Tidy","year":"2000","unstructured":"Tidy JA, Gillespie AM, Bright N et al (2000) Gestational trophoblastic disease: a study of mode of evacuation and subsequent need for treatment with chemotherapy. Gynecol Oncol 78(3 Pt 1):309\u2013312. https:\/\/doi.org\/10.1006\/gyno.2000.5839","journal-title":"Gynecol Oncol"},{"issue":"10","key":"1640_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1471-0528.1979.tb10694.x","volume":"86","author":"M Stone","year":"1979","unstructured":"Stone M, Bagshawe KD (1979) An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J Obstet Gynaecol 86(10):782\u2013792. https:\/\/doi.org\/10.1111\/j.1471-0528.1979.tb10694.x","journal-title":"Br J Obstet Gynaecol"},{"key":"1640_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1471-0528.1961.tb02778.x","volume":"68","author":"HD Attwood","year":"1961","unstructured":"Attwood HD, Park WW (1961) Embolism to the lungs by trophoblast. J Obstet Gynaecol Br Commonw 68:611\u2013617. https:\/\/doi.org\/10.1111\/j.1471-0528.1961.tb02778.x","journal-title":"J Obstet Gynaecol Br Commonw"},{"issue":"5\u20136","key":"1640_CR29","first-page":"219","volume":"61","author":"H Usui","year":"2016","unstructured":"Usui H, Kiyokawa T, Qu J et al (2016) Comparison between pathological diagnosis and cytogenetic diagnosis by short tandem repeat polymorphism analysis of suspected molar pregnancies. J Reprod Med 61(5\u20136):219\u2013223","journal-title":"J Reprod Med"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-020-01640-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:53:04Z","timestamp":1614991984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-020-01640-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01640-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"25 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflict of interest relevant to this article was reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}